• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Novartis

Novartis

Novartis AG ADR NVS

Last Price$86.04Day Change (%)1.32%
Open Price$86.25Day Change ($)1.12
Day Range85.85–86.3452-Week Range66.93–86.90

As of Fri 9/22/2017 4:04:00 PM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Novartis CEO Joe Jimenez to Step Down in January

    Novartis CEO Joe Jimenez to Step Down in January

  2. UPDATE: Novartis AG's CAR-T cell therapy for leukemia approved by FDA in 'historic action'; price to be based on outcomes

    UPDATE: Novartis AG's CAR-T cell therapy for leukemia approved by FDA in 'historic action'; price to be based on outcomes

  3. Novartis CEO Ends Turbulent Tenure -- WSJ

    Novartis CEO Ends Turbulent Tenure -- WSJ

  4. Novartis CEO to Step Down In January -- 3rd Update

    Novartis CEO to Step Down In January -- 3rd Update

  5. Novartis CEO to Step Down In January -- 2nd Update

    Novartis CEO to Step Down In January -- 2nd Update

  6. Novartis CEO to Step Down In January -- Update

    Novartis CEO to Step Down In January -- Update

  7. Novartis' CAR-T therapy was the first approved in U.S. -- here's how to invest in the space

    Novartis' CAR-T therapy was the first approved in U.S. -- here's how to invest in the space

  8. UPDATE: Novartis' CAR-T gene therapy, the first approved by FDA, to cost $475,000

    UPDATE: Novartis' CAR-T gene therapy, the first approved by FDA, to cost $475,000

  9. UPDATE: Novartis' CAR-T therapy was the first approved in U.S. -- here's how to invest in the space

    UPDATE: Novartis' CAR-T therapy was the first approved in U.S. -- here's how to invest in the space

  10. UPDATE: Novartis' CAR-T therapy was the first approved in U.S. -- here's how to invest in the space

    UPDATE: Novartis' CAR-T therapy was the first approved in U.S. -- here's how to invest in the space

12345

©2017 Morningstar Advisor. All right reserved.